Paper40977375
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features.
Nateghi Haredasht F and 15 others. J Am Med Inform Assoc, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. Papers, record 40977375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40977375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Machine Learning | Major topic |
| Opioid-Related Disorders | Major topic |
| Natural Language Processing | Major topic |
| Buprenorphine, Naloxone Drug Combination | Major topic |
| Opiate Substitution Treatment | Major topic |
| Narcotic Antagonists | Major topic |
| Humans | |
| Electronic Health Records | |
| Female | |
| Male | |
| ROC Curve | |
| Adult | |
| Logistic Models | |
| Buprenorphine |
Source PubMed
Grants17
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01AI17812101 | National Institute of Allergy and Infectious Diseases | R01AI178121 | PubMed | NIH RePORTER | |
| Google, Inc. | PubMed | PubMed | |||
| #12409 | Betty Moore Foundation | PubMed | PubMed | ||
| Human-Centered Artificial Intelligence | PubMed | PubMed | |||
| NIH | PubMed | PubMed | |||
| UG1DA015815 | NIH/National Institute on Drug Abuse Clinical Trials Network | UG1DA015815 | PubMed and NIH | NIH RePORTER | |
| Stanford Artificial Intelligence in Medicine and Imaging-Human-Centered Artificial Intelligence (AIMI-HAI) Partnership | PubMed | PubMed | |||
| 1R01AI17812101 | NIH/National Institute of Allergy and Infectious Diseases | R01AI178121 | PubMed | NIH RePORTER | |
| #12409 | Gordon and Betty Moore Foundation | PubMed | PubMed | ||
| UL1TR003142 | NIH-NCATS-CTSA | UL1TR003142 | PubMed and NIH | NIH RePORTER | |
| American Heart Association-Strategically Focused Research Network on Diversity in Clinical Trials | PubMed | PubMed | |||
| CTN-0136 | NIH/National Institute on Drug Abuse Clinical Trials Network | PubMed | PubMed | ||
| UG1DA015815 - CTN-0136 | National Institute on Drug Abuse Clinical Trials Network | UG1DA015815 | PubMed and NIH | NIH RePORTER | |
| Stanford Artificial Intelligence in Medicine and Imaging | PubMed | PubMed | |||
| UL1 TR003142 | NCATS NIH HHS | United States | UL1TR003142 | PubMed and NIH | NIH RePORTER |
| UG1 DA015815 | NIDA NIH HHS | United States | UG1DA015815 | PubMed and NIH | NIH RePORTER |
| UL1TR003142 | NIH HHS | United States | UL1TR003142 | PubMed and NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40127869 | A longitudinal observational study with ecological momentary assessment and deep learning to predict non-prescribed opioid use, treatment retention, and medication nonadherence among persons receiving medication treatment for opioid use disorder. | J Subst Use Addict Treat | 2025 | https://conductscience.org/library/papers/40127869 | PubMed |
| 2 | 7069920 | Evaluating the yield of medical tests. | JAMA | 1982 | https://conductscience.org/library/papers/7069920 | PubMed |
| 3 | 37037255 | A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models. | IEEE J Biomed Health Inform | 2023 | https://conductscience.org/library/papers/37037255 | PubMed |
| 4 | 26467975 | Retention in medication-assisted treatment for opiate dependence: A systematic review. | J Addict Dis | 2016 | https://conductscience.org/library/papers/26467975 | PubMed |
| 5 | 32239206 | Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults. | Epidemiol Rev | 2020 | https://conductscience.org/library/papers/32239206 | PubMed |
| 6 | 30675818 | Development of a Cascade of Care for responding to the opioid epidemic. | Am J Drug Alcohol Abuse | 2019 | https://conductscience.org/library/papers/30675818 | PubMed |
| 7 | 38045803 | Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/38045803 | PubMed |
| 8 | 25560730 | Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. | Ann Intern Med | 2015 | https://conductscience.org/library/papers/25560730 | PubMed |
| 9 | 32209915 | Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. | J Addict Med | 2020 | https://conductscience.org/library/papers/32209915 | PubMed |
| 10 | 35914118 | Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder. | J Addict Med | 2023 | https://conductscience.org/library/papers/35914118 | PubMed |
| 11 | 30352671 | Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. | J Subst Abuse Treat | 2018 | https://conductscience.org/library/papers/30352671 | PubMed |
| 12 | 34836524 | A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study. | BMC Med Inform Decis Mak | 2021 | https://conductscience.org/library/papers/34836524 | PubMed |
| 13 | 25623578 | Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. | BJOG | 2015 | https://conductscience.org/library/papers/25623578 | PubMed |
| 14 | 39585830 | Extraction of clinical data on major pulmonary diseases from unstructured radiologic reports using a large language model. | PLoS One | 2024 | https://conductscience.org/library/papers/39585830 | PubMed |
| 15 | 33079589 | Recommendations for Reporting Machine Learning Analyses in Clinical Research. | Circ Cardiovasc Qual Outcomes | 2020 | https://conductscience.org/library/papers/33079589 | PubMed |
| 16 | 35815386 | The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. | Addiction | 2023 | https://conductscience.org/library/papers/35815386 | PubMed |
| 17 | 39994821 | The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021. | Addiction | 2025 | https://conductscience.org/library/papers/39994821 | PubMed |
| 18 | 22626890 | Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. | Addict Behav | 2012 | https://conductscience.org/library/papers/22626890 | PubMed |
| 19 | 37716289 | Identification of opioid use disorder using electronic health records: Beyond diagnostic codes. | Drug Alcohol Depend | 2023 | https://conductscience.org/library/papers/37716289 | PubMed |
| 20 | 35255967 | Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. | Addict Sci Clin Pract | 2022 | https://conductscience.org/library/papers/35255967 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42844923 | From Innovation to Impact: The CREATE Framework as a Blueprint for Large Language Model Adoption in Opioid Treatment Programs. | J Med Internet Res | 2026 | https://conductscience.org/library/papers/42844923 | PubMed |
| 42773136 | A wearable acoustofluidic patch for rapid reversal of opioid overdose. | Nat Commun | 2026 | https://conductscience.org/library/papers/42773136 | PubMed |
| 42329422 | Natural language processing to enhance rheumatoid arthritis care in clinical studies: a scoping review of applications, data, approaches, challenges and future directions. | Rheumatol Int | 2026 | https://conductscience.org/library/papers/42329422 | PubMed |
| 42319872 | Integrating Psychosocial Factors into Artificial Intelligence Models for Predicting Addiction Treatment Outcomes: A Systematic Review. | Eur Addict Res | 2026 | https://conductscience.org/library/papers/42319872 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40977375
GET https://conductscience.org/api/papers/v1/40977375/references?page=2